Application of a Human Nasal Mucosa Ex Vivo Culture System to Model Inflammatory Responses
American Journal of Rhinology & Allergy · 19.11.2026
DOI: 10.1177/19458924261506401 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Rhinology & Allergy, online erschienen am 19.11.2026. Verfasst von Ju Lai und 10 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Shanghai Oriental Talent Programme, Shanghai General Hospital Integrated Traditional Chinese and Western Medicine, Shanghai Hospital Development Center foundation.
Abstract (Originalsprache)
Introduction
The nasal cavity is the entry point of the upper respiratory tract and the primary site of inflammatory responses to inhaled pathogens.
Methods
Human nasal mucosa (HNM) tissues were obtained from patients undergoing endoscopic nasal surgery. Six HNM specimens from patients with house dust mite (HDM)-allergic rhinitis were used for paired Der p 1 challenge experiments, and 8 chronic rhinosinusitis–derived HNM specimens were used for paired SARS-CoV-2 infection experiments. Histology, Reverse Transcription Quantitative Polymerase Chain Reaction, Enzyme-Linked Immunosorbent Assay, and bulk RNA sequencing were performed at the indicated time points.
Results
Cultured HNM maintained structural and functional integrity during short-term ex vivo culture. HDM stimulation enhanced secretory activity and induced IL-4 and IL-5 expression at day 3. Both SARS-CoV-2 variants (HU-1 and Omicron BA.2) produced detectable viral RNA and viral N-protein signals in HNM expressing Angiotensin-Converting Enzyme 2 and Transmembrane Protease Serine 2. Viral inoculation induced an interferon-associated antiviral response, which was most pronounced following HU-1 exposure, although between-variant differences in the measured antiviral markers were not significant. At 3 days postinfection under standardized infection conditions, HU-1 showed higher viral RNA burden and more marked epithelial injury than BA.2 at day 3.
Discussion
The ex vivo HNM model preserved key structural and cellular features of native nasal mucosa, including an intact epithelial barrier, stromal immune cells, and glandular components, supporting its use as a tissue-level platform that complements conventional 2-dimensional cultures. HDM-sensitized HNM showed Der p 1-associated type 2 responses, whereas the viral arm revealed an antiviral response and exploratory variant-associated differences in epithelial injury.
Conclusions
Short-term ex vivo HNM may provide a practical tissue-level platform for investigating upper-airway responses to allergen exposure and SARS-CoV-2 infection. It preserves multicellular tissue architecture, while further validation in larger, better-stratified cohorts and extended culture optimization will support broader mechanistic and translational application.
Förderung
- Shanghai Oriental Talent Programme
- Shanghai General Hospital Integrated Traditional Chinese and Western Medicine
- Shanghai Hospital Development Center foundation
- National Key Research and Development Program of China
- National Science Foundation of Shanghai
Zitieren
APA
Lai, J., Peng, H., Zhou, S., Yao, C., Zhang, Z., Fan, K., Gao, Y., Jin, L., Gao, Z., Zhao, P., & Yu, S. (2026). Application of a Human Nasal Mucosa Ex Vivo Culture System to Model Inflammatory Responses. American Journal of Rhinology & Allergy. https://doi.org/10.1177/19458924261506401
Vancouver
Lai J, Peng H, Zhou S, Yao C, Zhang Z, Fan K, et al. Application of a Human Nasal Mucosa Ex Vivo Culture System to Model Inflammatory Responses. American Journal of Rhinology & Allergy. 2026. doi:10.1177/19458924261506401
BibTeX
@article{Lai2026,
author = {Lai, Ju and Peng, Haoran and Zhou, Shican and Yao, Chunyan and Zhang, Zhili and Fan, Kai and Gao, Yawen and Jin, Ling and Gao, Zhengliang and Zhao, Ping and Yu, Shaoqing},
title = {Application of a Human Nasal Mucosa Ex Vivo Culture System to Model Inflammatory Responses},
journal = {American Journal of Rhinology & Allergy},
year = {2026},
doi = {10.1177/19458924261506401}
}
EUVIMED